Current Diabetes Reports

, Volume 6, Issue 4, pp 297–304

Hypertension and the pregnancy complicated by diabetes

  • Gustavo F. Leguizamón
  • Natalia P. Zeff
  • Alberto Fernández


Diabetes is a frequent complication of pregnancy. Type 1 diabetes is associated with an increased incidence of preeclampsia and pregnancy-induced hypertension. When renal dysfunction is present, the incidence of these complications is remarkably increased. White's class, poor glycemic control during the first half of pregnancy, and early blood pressure elevation are also independent risk factors for developing preeclampsia. Whether gestational diabetes increases the background incidence of preeclampsia is still debated. Because therapeutic interventions such as low-dose aspirin and antioxidants have not been shown to be effective, preventive measures rely on tight blood glucose control, as well as adequate blood pressure treatment.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Conquering Diabetes. A Strategic Plan for the 21st Century. A report of the congressionally established diabetes research working group 1999. NIH publication No. 99- 4398. Scholar
  2. 2.
    ACOG Committee on Practice Bulletins: ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists. Number 60, March 2005. Pregestational diabetes mellitus. Obstet Gynecol 2005, 105:675–685.Google Scholar
  3. 3.
    American Diabetes Association: Gestational diabetes mellitus. Diabetes Care 2004, 27(suppl 1):S88-S90.Google Scholar
  4. 4.
    Brody SC, Harris R, Lohr K: Screening for gestational diabetes: a summary of the evidence for the U.S. Preventive Services Task Force. Obstet Gynecol 2003, 101:380–392.PubMedCrossRefGoogle Scholar
  5. 5.
    Bernasko J: Contemporary management of type 1 diabetes mellitus in pregnancy. Obstet Gynecol Surv 2004, 59:628–636.PubMedCrossRefGoogle Scholar
  6. 6.
    Hiilesmaa V, Suhonen L, Teramo K: Glycaemic control is associated with pre-eclampsia but not with pregnancyinduced hypertension in women with type I diabetes mellitus. Diabetologia 2000, 43:1534–1539.PubMedCrossRefGoogle Scholar
  7. 7.
    Hanson U, Persson B: Epidemiology of pregnancy-induced hypertension and preeclampsia in type I (insulin-dependent) diabetic pregnancies in Sweden. Acta Obstet Gynecol Scand 1998, 77:620–624.PubMedCrossRefGoogle Scholar
  8. 8.
    Miodovnik M, Rosenn BM, Khoury JC, et al.: Does pregnancy increase the risk for development and progression of diabetic nephropathy? Am J Obstet Gynecol 1996, 74:1180–1189; discussion 1189–1191.CrossRefGoogle Scholar
  9. 9.
    Sibai BM, Caritis S, Hauth J, et al.: Risks of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes mellitus. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol 2000, 182:364–369.PubMedCrossRefGoogle Scholar
  10. 10.
    Combs CA, Rosenn B, Kitzmiller JL, et al.: Early-pregnancy proteinuria in diabetes related to preeclampsia. Obstet Gynecol 1993, 82:802–807.PubMedGoogle Scholar
  11. 11.
    Reece EA, Coustan DR, Hayslett, et al.: Diabetic nephropathy: pregnancy performance and fetomaternal outcomes. Am J Obstet Gynecol 1988, 159:56–66.PubMedGoogle Scholar
  12. 12.
    Kimmerle R, Zass RP: Pregnancies in women with diabetic nephropathy: long-term outcome for mother and child. Diabetologia 1995, 38:227–235.PubMedGoogle Scholar
  13. 13.
    Gordon M, Landon MB, Samuels P, et al.: Perinatal outcome and long-term follow-up associated with modern management of diabetic nephropathy. Obstet Gynecol 1996, 87:401–409.PubMedCrossRefGoogle Scholar
  14. 14.
    Reece EA, Leguizamon G, Homko C: Pregnancy performance and outcomes associated with diabetic nephropathy. Am J Perinatol 1998, 15:413–421.PubMedGoogle Scholar
  15. 15.
    Sibai BM: Risk factors, pregnancy complications, and prevention of hypertensive disorders in women with pregravid diabetes mellitus. J Matern Fetal Med 2000, 9:62–65. A review of the rate, risk factors, and potential prevention of preeclampsia in women with PGDM.PubMedCrossRefGoogle Scholar
  16. 16.
    Cousins L: Obstetric complications in diabetic pregnancies. In Diabetes in Women. Adolescence, Pregnancy, and Menopause. Edited by Reece EA, et al. Philadelphia: Lippincott, Williams, & Wilkins; 2004:351–362.Google Scholar
  17. 17.
    Cousins LM: Pregnancy complications among diabetic women: review 1965–1985. Obstet Gynecol Surv 1987, 42:140–147.PubMedGoogle Scholar
  18. 18.
    Garner PR, D'Alton ME, Dudley DK, et al.: Preeclampsia in diabetic pregnancies. Am J Obstet Gynecol 1990, 163:505–508.PubMedGoogle Scholar
  19. 19.
    Siddiqi T, Rosenn B, Mimouni F, et al.: Hypertension during pregnancy in insulin-dependent diabetic women. Obstet Gynecol 1991, 77:514–519.PubMedGoogle Scholar
  20. 20.
    Rudge M, Calderon I, Ramos M, et al.: Hypertensive disorders in pregnant women with diabetes mellitus. Gynecol Obstet Invest 1997, 44:11–15.PubMedCrossRefGoogle Scholar
  21. 21.
    Cundy T, Slee F, Gamble G, et al.: Hypertensive disorders of pregnancy in women with type 1 and type 2 diabetes. Diabet Med 2002, 19:482–489.PubMedCrossRefGoogle Scholar
  22. 22.
    Leguizamon G, Reece EA: Effect of medical therapy on progressive nephropathy: influence of pregnancy, diabetes and hypertension. J Matern Fetal Med 2000, 9:70–78.PubMedCrossRefGoogle Scholar
  23. 23.
    Ritz E, Orth SR: Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med 1999, 341:1127–1133.PubMedCrossRefGoogle Scholar
  24. 24.
    Kitzmiller JL, Brown ER, Phillippe M, et al.: Diabetic nephropathy and perinatal outcome. Am J Obstet Gynecol 1981, 141:741–751.PubMedGoogle Scholar
  25. 25.
    Reece EA, Leguizamon GF, Homko C: Stringent controls in diabetic nephropathy associated with optimisation of pregnancy outcomes. J Matern Fetal Med 1998, 7:213–216.PubMedCrossRefGoogle Scholar
  26. 26.
    Ekbom P, Damm P, Feldt-Rasmussen B, et al.: Pregnancy outcome in type 1 diabetic women with microalbuminuria. Diabetes Care 2001, 24:1739–1744.PubMedCrossRefGoogle Scholar
  27. 27.
    How HY, Sibai B, Lindheimer M, et al.: Is early-pregnancy proteinuria associated with an increased rate of preeclampsia in women with pregestational diabetes mellitus? Am J Obstet Gynecol 2004, 190:775–778.PubMedCrossRefGoogle Scholar
  28. 28.
    Hsu CD, Hong SF, Nickless NA, Copel JA: Glycosylated hemoglobin in insulin-dependent diabetes mellitus related to preeclampsia. Am J Perinatol 1998, 15:199–202.PubMedGoogle Scholar
  29. 29.
    Wang Y, Walsh SW: Antioxidant activities and mRNA expression of superoxide dismutase, catalase, and glutathione peroxidase in normal and preeclamptic placentas. J Soc Gynecol Investig 1996, 3:179–84.PubMedCrossRefGoogle Scholar
  30. 30.
    Giugliano D, Ceriello A, Paolisso G: Oxidative stress and diabetic vascular complications. Diabetes Care 1996, 19:257–267.PubMedCrossRefGoogle Scholar
  31. 31.
    Arauz-Pacheco C, Parrott MA, Raskin P: Treatment of hypertension in adults with diabetes. Diabetes Care 2003, 26(supp 1): S80-S82.PubMedGoogle Scholar
  32. 32.
    Caritis S, Sibai B, Hauth J, et al.: Predictors of pre-eclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol 1998, 179:946–951.PubMedCrossRefGoogle Scholar
  33. 33.
    Duckitt K, Harrington D: Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 2005, 330:565.PubMedCrossRefGoogle Scholar
  34. 34.
    Lauszus FF, Rasmussen OW, Lousen T, et al.: Ambulatory blood pressure as predictor of preeclampsia in diabetic pregnancies with respect to urinary albumin excretion rate and glycemic regulation. Acta Obstet Gynecol Scand 2001, 80:1096–1103.PubMedCrossRefGoogle Scholar
  35. 35.
    Ekbom P, Damm P, Nogaard K, et al.: Urinary albumin excretion and 24-hour blood pressure as predictors of pre-eclampsia in type I diabetes. Diabetologia 2000, 43:927–931.PubMedCrossRefGoogle Scholar
  36. 36.
    Vambergue A, Nuttens MC, Goeusse P, et al.: Pregnancy induced hypertension in women with gestational carbohydrate intolerance: the diagest study. Eur J Obstet Gynecol Reprod Biol 2002, 102:31–35. This study compared the incidence of PIH in three groups according to different gestational glucose intolerance. PIH appears to be linked to the level of glucose intolerance during pregnancy, independently of other known factors of hypertension.PubMedCrossRefGoogle Scholar
  37. 37.
    Joffe GM, Esterlitz JR, Levine RJ, et al.: The relationship between abnormal glucose tolerance and hypertensive disorders of pregnancy in healthy nulliparous women. Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol 1998, 179:1032–1037.PubMedCrossRefGoogle Scholar
  38. 38.
    Casey BM, Lucas MJ, MCIntire DD, et al.: Pregnancy outcomes in women with gestational diabetes compared with the general obstetric population. Obstet Gynecol 1997, 90:869–873.PubMedCrossRefGoogle Scholar
  39. 39.
    Jensen DM, Sorensen B, Feilberg-Jorgensen N, et al.: Maternal and perinatal outcomes in 143 Danish women with gestational diabetes mellitus and 143 controls with a similar risk profile. Diabet Med 2000, 17:281–286.PubMedCrossRefGoogle Scholar
  40. 40.
    Schaffir JA, Lockwood CJ, Lapinski R, et al.: Incidence of pregnancy-induced hypertension among gestational diabetics. Am J Perinatol 1995, 12:252–254.PubMedCrossRefGoogle Scholar
  41. 41.
    Sermer M, Naylor CD, Gare DJ, et al.: Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without gestational diabetes. The Toronto Tri-Hospital Gestational Diabetes Project. Am J Obstet Gynecol 1995, 173:146–156.PubMedCrossRefGoogle Scholar
  42. 42.
    Yogev Y, Xenakis EMJ, Langer O: The association between preeclampsia and the severity of gestational diabetes: the impact of glycemic control. Am J Obstet Gynecol 2004, 191:1655–1660.PubMedCrossRefGoogle Scholar
  43. 43.
    Caritis S, Sibai B, Hauth J, et al.: Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 1998, 338:701–705.PubMedCrossRefGoogle Scholar
  44. 44.
    CLASP: a randomized trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnancy women. CLASP Collaborative Low Dose Aspirin Study in Pregnancy Collaborative Group [no authors listed]. Lancet 1994, 343:619–629.Google Scholar
  45. 45.
    Coomarasamy A, Honest H, Papaioanno S, et al.: Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review. Obstet Gynecol 2003, 101:1319–1332.PubMedCrossRefGoogle Scholar
  46. 46.
    Roberts JM, Gammill HS: Preeclmapsia: recent insights. Hypertension 2005, 46:1243–1249.PubMedCrossRefGoogle Scholar
  47. 47.
    Poston L, Brilley AL, Kelly FJ, et al.: Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomized placebo-controlled trial. Available online at Accessed March 30, 2006.Google Scholar

Copyright information

© Current Science Inc 2006

Authors and Affiliations

  • Gustavo F. Leguizamón
    • 1
  • Natalia P. Zeff
  • Alberto Fernández
  1. 1.Diabetes in Pregnancy Unit, Department of Obstetrics and GynecologyCenter of Medical Education and Clinical Research (C.E.M.I.C.) UniversityBuenos AiresArgentina

Personalised recommendations